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Systematic identification of mitotic phosphoproteins 
P. Todd Stukenberg*, Kevin D. Lustig*, Thomas J. McGarry*, Randall W. King*,
Jian Kuang† and Marc W. Kirschner*
Background: Cyclin-dependent kinases (CDKs) are thought to initiate and
coordinate cell division processes by sequentially phosphorylating key targets; in
most cases these substrates remain unidentified.
Results: Using a screen that scores for phosphorylation of proteins, which were
translated from pools of cDNA plasmids in vitro, by either phosphoepitope
antibody recognition or electrophoretic mobility shifts, we have identified 20
mitotically phosphorylated proteins from Xenopus embryos, 15 of which have
sequence similarity to other proteins. Of these proteins, five have previously been
shown to be phosphorylated during mitosis (epithelial-microtubule associated
protein-115, Oct91, Elongation factor 1g, BRG1 and Ribosomal protein L18A),
five are related to proteins postulated to have roles in mitosis (epithelial-
microtubule associated protein-115, Schizosaccharomyces pombe Cdc5, inner-
centrosome protein, BRG1 and the RNA helicase WM6), and nine are related to
transcription factors (BRG1, negative co-factor 2a, Oct91, S. pombe Cdc5,
HoxD1, Sox3, Vent2, and two isoforms of Xbr1b). Of 16 substrates tested, 14
can be directly phosphorylated in vitro by the mitotic CDK, cyclin B–Cdc2,
although three of these may be physiological substrates of other kinases
activated during mitosis. 
Conclusions: Examination of this broad set of mitotic phosphoproteins has
allowed us to draw three conclusions about how the activation of CDKs
regulates cell-cycle events. First, Cdc2 itself appears to directly phosphorylate
most of the mitotic phosphoproteins. Second, during mitosis most of the
substrates are phosphorylated more than once and a number may be targets of
multiple kinases, suggesting combinatorial regulation. Third, the large fraction of
mitotic phosphoproteins that are presumptive transcription factors, two of which
have been previously shown to dissociate from DNA during mitosis, suggests
that an important function of mitotic phosphorylation is to strip the chromatin of
proteins associated with gene expression. 
Background
Protein phosphorylation is an important regulator of the
cell-cycle transition from interphase to mitosis; several
protein kinases are required [1–6], and there is a dramatic
increase in phosphate turnover during mitosis, accom-
plished by activating both protein kinases and protein
phosphatases [7,8]. Over 50 proteins become specifically
phosphorylated in mitosis and react with the anti-phospho-
epitope monoclonal antibody MPM-2 [9]. This antibody
stains kinetochores, centrosomes, polar microtubules, and
the central axis of chromosomes, suggesting that the
mitotic reorganization of most of the structural components
of the cell may be under phosphorylation control [10,11]. 
The cell cycle is controlled by a family of cyclin-depen-
dent kinases (CDKs), which are sequentially activated by
the synthesis and destruction of their cyclin regulatory
subunits (reviewed in [12]). In metazoans, there appears
to be temporal regulation of two families of mitotic
cyclins, namely A-type and B-type cyclins. It is believed
that the complex of Cdc2 (also known as p34cdc2) and
cyclin A is activated in G2 and early prophase, whereas
complexes of both A-type and B-type cyclins with Cdc2
are activated during prophase and metaphase, and only
B-type cyclins are present during late metaphase, after the
A-type cyclins have been degraded [4,13,14]. 
To understand how an enzyme regulates a biological
process, it is first necessary to identify its substrates. We
know that activation of Cdc2 is necessary to trigger
mitosis, but only through the identification of a few key
substrates have we gained an insight into how this is
accomplished. For example, mutagenesis of the Cdc2
phosphorylation sites on lamin A inhibits nuclear envelope
breakdown, demonstrating that Cdc2 can directly control a
structural component of the cell that is remodeled during
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mitosis [15,16]. Yet most of Cdc2’s key targets involved in
other mitotic events have not been identified. Cell-cycle
regulation is further complicated by the fact that many
substrates are regulated by multiple kinases. For example,
there are additional mitotically phosphorylated sites on
lamins [17] that are targets of the b isoform of protein
kinase C (PKC), and still other sites for which the kinase is
not known [18]. Genetic and biochemical studies have
identified several protein kinases essential for mitosis
[6,19]: although the best characterized are the CDKs
[1,4–6], additional kinases such as NimA, isoforms of PKC,
and Polo/Cdc5 are thought to be essential for mitotic pro-
gression [2,3,18,19]. It remains unclear whether these
identified protein kinases are responsible for the bulk of
mitotic phosphorylation, or whether they serve limited
roles in mitosis — additional uncharacterized kinases may
also participate in mitotic events. 
Identifying either a complete or arbitrarily chosen set of
cell-cycle specific phosphoproteins could be useful in
examining cell-cycle regulation. By determining the per-
centage of proteins that are recognized by CDKs, one
could assess the relative contributions of CDKs and other
kinases to cell-cycle specific phosphorylation. Moreover,
the characterization of these phosphoproteins should iden-
tify the kinase substrates that are regulating cell-cycle
events, and the proteins could be used to detect previ-
ously unidentified cell-cycle specific kinase activities.
Unfortunately, such unbiased sets of cell-cycle specific
phosphoproteins cannot be generated with existing tech-
niques, with which kinase substrates are detected by
testing known proteins with known kinases. 
In this study, we present a systematic and broadly applica-
ble screen for kinase substrates. We have translated in
vitro cDNA pools consisting of only 100 clones from a
Xenopus laevis gastrula-stage library [20,21] to directly
prepare pools of 35S-labeled proteins. The phosphoryla-
tion of these library proteins by kinases in mitotic and
interphase cell extracts was detected either by scoring for
phosphatase-sensitive alterations in mobility when ana-
lyzed by SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) or by immunoprecipitation with phospho-
epitope-recognizing antibodies. Using this approach, we
have isolated cDNAs encoding 20 proteins that are phos-
phorylated in a mitosis-specific manner. The genes we
isolated using these cDNAs encode previously identified
regulators of mitosis as well as novel proteins. Not all of
these putative mitotic phosphoproteins can be directly
phosphorylated by Cdc2, suggesting that they must be
substrates of other mitotic kinases. 
Results
Development of a screen for mitotic phosphoproteins
Whether a protein is phosphorylated in vivo is determined
by factors that may change dramatically during the cell
cycle, including the affinity of the kinase for the substrate,
the localization of kinases and substrates, the activity of
phosphatases, and the activity of kinase docking and
accessory factors [22]. As these dynamics are often lost
upon enzyme purification, we have instead used cell-cycle
staged Xenopus egg extracts to study mitotic phosphoryla-
tion. Interphase extracts form nuclei around DNA and
replicate the chromosomes once and only once, and
mitotic extracts are able to disassemble nuclear envelopes,
condense chromosomes, and form metaphase spindles
[23,24], recapitulating the events of the cell cycle in vitro.
The extracts would therefore be expected to reproduce
physiological phosphorylation and dephosphorylation.
Thus, using these extracts, we hoped to test not only the
capacity of a site for phosphorylation but the stoichiometry
of that event in a physiologically relevant cellular milieu. 
We have developed two complementary approaches to
identifying mitotic phosphoproteins (Fig. 1a). In both
approaches, pools of clones from a Xenopus gastrula-stage
cDNA library (containing approximately 100 clones per
pool) were first transcribed and translated in vitro to gener-
ate pools of radiolabeled proteins. These protein pools
were then incubated in mitotic or interphase Xenopus egg
extracts. Proteins that become phosphorylated after incu-
bation in the mitotic, but not the interphase, extract were
identified by looking for alterations in their mobility upon
gel electrophoresis. Alternatively, mitosis-specific phos-
phorylation of the radiolabeled library proteins was
detected by immunoprecipitation with the anti-phospho-
epitope antibody MPM-2.
We used the mitotic phosphatase, Cdc25 (from Xenopus),
as a positive control in both assays; the mitotic form of
Cdc25 is recognized by the MPM-2 antibody and migrates
more slowly than its interphase form upon gel elec-
trophoresis [25,26]. The protein kinase Cdc2 (from
Xenopus) was used as a negative control, as its gel mobility
does not change nor does it become reactive to the
MPM-2 antibody. After incubation in a Xenopus mitotic
extract, in vitro translated Cdc25, but not Cdc2, migrated
with a reduced mobility and was immunoprecipitated by
the MPM-2 antibody (Fig. 1b). When either protein was
incubated in an interphase extract, its mobility was not
affected and it was not appreciably immunoprecipitated
by the MPM-2 antibody. 
Identification of mitotic phosphoproteins
In the screen for gel-mobility shifts, 69 library pools out of
232 tested contained at least one protein whose mitotic
form migrated more slowly than its interphase form. Two
examples of positive pools are shown in Figure 1c. Almost
all of the proteins in each pool had a similar mobility after
incubation in interphase or mitotic extracts — the arrows
point to the single protein in each pool with a reduced
mobility after incubation in mitotic extracts. This reduced
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mobility was phosphatase sensitive (data not shown),
suggesting that it was indeed a consequence of mitotic
kinase activity. The extent of the mobility shift varied
considerably between different clones, with the apparent
molecular mass changes ranging from 1 to 30 kD. The
mobility change of a single protein within a pool was very
reproducible from experiment to experiment.
Some of the positive pools (14/69) were selected for sub-
division because they contained proteins that showed a
large shift in mitotic extracts and were of different appar-
ent molecular masses. These pools were progressively sub-
divided and retested until single active clones were
identified (Table 1). The cloned cDNAs encoded nine dif-
ferent proteins, which we hereafter refer to as mitotic phos-
phoproteins (MPs); newly identified MPs were named by
appending the apparent molecular mass of the gene
product. One MP, Sox3, was identified three times, MP105
was identified twice, and the other seven MPs were each
identified once. When tested individually, all nine MPs
reproducibly exhibited phosphatase-sensitive reductions in
gel mobility when incubated in mitotic extracts (Fig. 2a).
For example, MP68 stoichiometrically shifted from a single
band of an apparent molecular weight of 68 kD in an inter-
phase extract to a doublet of 75 and 77 kD in a mitotic
extract; this reduction in mobility was sensitive to phos-
phatase treatment (Fig. 2a; compare the mobility of MP68
in lanes 1, 2 and 3). MP110, by contrast, was not stoichio-
metrically shifted in mitotic extracts, but instead ran on
SDS gels as a smear of slower migrating species. Many
MPs displayed multiple phosphorylated forms which
appeared as smears on SDS gels following incubation in
mitotic extracts (Fig. 2a); these smears suggest that the
proteins are heterogeneously phosphorylated.
A complementary screen was performed using MPM-2
antibody recognition as an assay of mitotic phosphoryla-
tion. The pools contained between 20 and 30 labeled pro-
teins (Fig. 1d, lanes 1,4,7), most of which were not
recognized by the MPM-2 antibody after incubation in
either interphase or mitotic extracts (Fig. 1d). A few pro-
teins were immunoprecipitated after incubation in either
extract; the arrows in Figure 1d point to proteins that were
only immunoreactive after incubation in a mitotic extract.
Several pools tested (36/265) contained a protein that
could be immunoprecipitated with the MPM-2 antibody
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A novel screen for mitotic phosphoproteins. (a) A systematic screen for
mitotic phosphoproteins. Pools of approximately 100 cDNA library
plasmids were translated in vitro (IVT) to produce pools of 15–30
proteins. These proteins were phosphorylated in Xenopus extracts, and
the mitotically phosphorylated proteins were detected by either MPM-2
immunoprecipitation (anti-phosphoepitope IP) or by retarded gel mobility.
(b) Analysis of Cdc25 and Cdc2 using the two assays for mitotic
phosphorylation. Cdc25 and Cdc2 were labeled with 35S during
translation in vitro, incubated in an interphase (I) or mitotic (M) extract,
immunoprecipitated with the MPM-2 monoclonal antibody, and the
labeled proteins both in the supernatant (S) and on the washed beads
(P) were visualized by electrophoresis and autoradiography. 
(c) Two examples of pools containing mitotic phosphoproteins detected
by reduced gel mobility. Pools of approximately 100 cDNAs from a
Xenopus gastrula-stage library were 35S-labeled during translation in
vitro and incubated in either an interphase (I) or mitotic (M) extract and
analyzed by SDS–PAGE and autoradiography. Positive proteins (marked
with an arrow) migrate slower after incubation in the mitotic extract than
after incubation in the interphase extract. (d) Three examples of cDNA
pools in the screen detecting mitotic phosphorylation using the MPM-2
antibody. Pools of approximately 100 cDNAs from a Xenopus gastrula-
stage library were treated as in (b), except that non-immunoprecipitated
material was not analyzed. Arrows indicate positive bands. The position
of molecular weight markers (in kDa) are shown on the right side of gels.
in a mitosis-specific manner. Of the 36 positive pools, the
first 12 that contained bands which were clearly immuno-
precipitable by the MPM-2 antibody were subdivided and
retested to yield 11 unique cDNA clones (Table 1). One
of these, encoding MP25, was isolated twice, and the
other 10 clones were isolated once each. 
Characterization of the mitotic phosphorylation patterns of
the individual MPs isolated by MPM-2 recognition is
shown in Figure 2b. For example, the clone MP44 was
stoichiometrically shifted from a 44 kD species in inter-
phase extracts to a smear of forms that ranged in apparent
molecular weight from 50 to 55 kD in mitotic extracts
(Fig. 2b; compare lanes 2 and 3); all of these mitotically
shifted species were recognized by the MPM-2 antibody
(Fig. 2b, lanes 4,5). By contrast, although MP43 was also
stoichiometrically shifted in mitotic extracts (Fig. 2b;
compare lanes 2 and 3), only some of the phosphorylated
forms were recognized by MPM-2 (Fig. 2b, lanes 4,5).
There were eight MPs that exhibited a gel-mobility shift
after incubation in mitotic extract (Fig. 2b, lanes 2,3;
Table 1), and as single clones, nine of eleven MPs were
recognized by MPM-2 after incubation in mitotic extract
(Fig. 2b, lanes 4,5; Table 1). Two proteins (Vent2 and
MP70) were recognized by MPM-2 only if the phos-
phatase inhibitor okadaic acid was included in the mitotic
extract (data not shown); both these proteins exhibited
gel-mobility shifts in mitotic extracts. Three MPs showed
no obvious gel shifts but were still identified by the
MPM-2 antibody in the mitotic state, demonstrating that
the two screening approaches were complementary. 
In the described MPM-2 recognition screen, MPM-2
immunoprecipitations were performed under native condi-
tions, and it was therefore possible that we had detected
proteins that bound to other proteins that themselves had
MPM-2 immunoreactivity. In order to address this
possibility, the individual clones were denatured after incu-
bation in extracts, and then immunoprecipitated. Under
denaturing conditions, five of the nine proteins (MP90,
MP43, MP44, HoxD1 and MP42) could be precipitated by
MPM-2 and therefore can be called ‘true’ MPM-2 antigens
(Fig. 2b, first five clones). The other proteins could be pre-
cipitated by MPM-2 only under native conditions, and
therefore they might associate with other MPM-2 antigens,
or they may only be recognized by MPM-2 under native
conditions. The human homolog of one of these proteins,
MP20, was previously identified as a true MPM-2 antigen
[27]. Ribosomal elongation factor 1g (EF1g) was previously
shown to be a mitotic phosphoprotein [28], and MP130 had
a retarded migration on SDS gels after incubation in a
mitotic extract; hence, even the MPM-2 antigens that
could be immunoprecipitated only under native conditions
are probably phosphorylated mitotically in vivo. 
In summary, using both of our screening approaches, we
have screened a total of about 500 pools of cDNAs (encod-
ing approximately 12 000 proteins), and have identified
105 pools that contain potential mitotic phosphoproteins.
Of these positive pools, 26 have thus far been progres-
sively subdivided to yield 17 cDNAs that code for proteins
that displayed reduced mobility after incubation in mitotic
extracts, and 3 additional clones that code for proteins that
either are themselves mitotic phosphoproteins or were
detected in complexes with proteins containing MPM-2
antigens (Table 1). The screen is clearly not yet saturated:
there are many more positive pools to be subdivided, and
only three clones (MP105, Sox3 and MP25) were identi-
fied more than once each.
Sequence analysis of cloned mitotic phosphoproteins
The cDNA insert from each of the 20 plasmid clones iso-
lated was partially sequenced and compared to sequences
in the GenBank nonredundant database [29]. Fifteen of the
clones are related to previously identified proteins (Table
2). Seven of the clones have been previously cloned in
Xenopus — those encoding Oct91, HoxD1, Vent2, EF1g,
Sox3 and two isoforms of Xbr1 — and seven others exhibit
strong sequence similarity to genes previously cloned from
other species — those encoding MP130 (inner-centrosome
protein; INCENP), MP110 (Schizosaccharomyces pombe
Cdc5), MP30 (negative co-factor 2a; NC-2a), MP70
(BRG1/Swi2), MP25 (RNA helicase WM6), MP20 (riboso-
mal protein L18A) and MP105 (a glycophosphatidylinositol
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Table 1
Summary of mitotic phosphoprotein screening.
Positive pools that Different Single clones Single clones immuno-
Protein pools Positive pools were progressively proteins that shift in precipitated by MPM-2
Screening assay screened identified subdivided identified mitotic extracts (native/denaturing)
Mitosis-specific 232 69 14 9 9 Not determined
mobility retardation (~5 600 proteins)
MPM-2 265 36 12 11 8 9/5
recognition (~6 300 proteins)
Total 497 105 26 20 17 9/5
(~12 000 proteins)
(GPI)-anchored protein). The homology between MP75
and the epithelial-microtubule associated protein-115 (E-
MAP-115) is significant, but divergent enough that the
protein may represent a novel microtubule associated
protein. The degree of amino-acid identity between the
sequenced region of each cDNA and the related sequence
in GenBank is summarized in Table 2. Of the previously
identified proteins, 8 out of 15 either have been previ-
ously shown to be phosphorylated during mitosis or have
been postulated to have a mitotic role (Table 2, and see
Discussion).
The sequenced regions of the other five putative sub-
strates identified do not bear significant similarity to
known proteins. MP90 and MP44, however, are homolo-
gous to open reading frames identified in the budding
yeast and Caenorhabditis elegans genome sequencing pro-
jects (Table 2). A search for a conserved domain or motif
among all the clones was unproductive, although most of
the MPs contain a region that has multiple serine–proline
or threonine–proline pairs (data not shown), including
consensus phosphorylation sites for Cdc2 and mitogen-
activated protein (MAP) kinase (Table 2). A similar motif
is mitotically phosphorylated in Cdc25 [30], and is found
in many mitotic regulators including Wee1 and Cdc27
[31]. There are 35 consensus Cdc2 or MAP kinase phos-
phorylation sites in the 18 substrates we have identified
that have been fully sequenced; only 8 such sites would
be predicted to occur in a similar amount of random
sequence, and when we searched 20 protein sequences
picked at random, the sites were detected 12 times (P.T.S.
and M.W.K., unpublished observations).
X-INCENP is a physiologic substrate of mitotic kinases
In order to establish that the INCENP-related protein,
MP130 (hereafter referred to as Xenopus INCENP;
X-INCENP), is a mitotic phosphoprotein in vivo, we used
a cross-reacting antibody raised against chicken INCENP
to examine the phosphorylation of endogenous
X-INCENP during early embryonic cell cycles. Xenopus
eggs were fertilized and, at intervals thereafter, embryos
were lysed in buffer containing both kinase and phos-
phatase inhibitors (Fig. 3); a portion was removed to assay
kinase activity against histone H1, and the rest was diluted
into SDS-containing sample buffer for immunoblot analy-
sis. Figure 3a shows that the change in relative mobility of
X-INCENP incubated in Xenopus extracts in vitro was
similar to the change in mobility observed in vivo. Two
mobility forms of the protein were observed following
incubation in interphase extracts of in vitro translated X-
INCENP; endogenous X-INCENP showed a similar
mobility pattern when isolated from interphase embryos.
The slower migrating form may be unphosphorylated, as it
comigrated with the phosphatase-treated protein (Fig. 3a;
compare lanes 1 and 3). The X-INCENP protein exhib-
ited reduced mobility in mitotic extracts and in embryos
that were in the mitotic phase of the cell cycle (Fig. 3a;
compare lanes 2 and 5). As Xenopus embryos traversed the
early cell cycles, the appearance of the slowest migrating
form of X-INCENP correlated with increased kinase activ-
ity, assessed using histone H1 as a substrate (Fig. 3b) — a
measure of Cdc2 activity. This data suggests that our
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Figure 2
Analysis of the mitotic phosphorylation of single clones. (a) Analysis of
the MPs identified by SDS–PAGE retardation. The MPs selected by
progressive subdivision of pools were 35S-labeled by translation in vitro,
and incubated in five separate reactions: in an interphase extract (I), in a
mitotic extract (M), in a mitotic extract followed by incubation with calf
intestinal phosphatase (M + CIP); with affinity purified cyclin B1–Cdc2
(CycB–cdc2); or with Cdc2 mock purified with beads without the
affinity reagent (Cdc2 control). After the incubations, the reactions were
directly analyzed by SDS–PAGE and autoradiography. (b) Analysis of
11 MPs identified by MPM-2 recognition. After progressive subdivision
to a single clone, each MP indicated was 35S-labeled during translation
in vitro, and the reaction was split into three. The translated protein was
analyzed by SDS–PAGE either directly (IVT) or after incubation in either
interphase (I) or mitotic (M) extracts. Incubated samples were either
directly loaded onto the gel (lanes 2,3) or first precipitated with the
MPM-2 monoclonal antibody (MPM-2 IP; lanes 4,5). The first 7 clones
(MP90 through to MP70) were denatured by boiling for 5 min in 2%
SDS, and centrifuged for 5 min before precipitation with MPM-2 beads.
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screen is capable of identifying physiological protein
kinase substrates.
Phosphorylation of mitotic phosphoproteins by Cdc2 and
by distinct mitotically activated kinases
Although CDKs have been demonstrated to phosphorylate
certain substrates directly during mitosis, CDKs could also
act indirectly to modify the phosphorylation state of a
protein. For example, CDKs could either activate a down-
stream mitotic kinase, inhibit a phosphatase to reveal a con-
stitutive kinase activity, modify a substrate so that it can be
phosphorylated by another kinase, or regulate proteins that
render substrates sensitive to other kinases. To determine
whether Cdc2 can directly phosphorylate the identified
MPs, the individual in vitro translated proteins were incu-
bated with affinity-purified cyclin B–Cdc2 (Fig. 2a, lane 4),
and the mobility of the protein on SDS gels was compared
with the mobility of the proteins observed following incu-
bation in either mitotic extracts (Fig. 2a, lane 2) or mock-
purified kinase solutions (Fig. 2a, lane 5). The level of
histone H1 kinase activity was titrated to about the same
level as that found in a mitotic extract; in the absence of
phosphatases, this presumably represents a large excess of
kinase activity. Of the 16 proteins assayed, 14 exhibited
reduced mobility after incubation with cyclin B–Cdc2 (Fig.
2a; Table 2). The full mobility shift of MP68, MP48,
MP110, Xbr1b, Oct91 and MP30 could be reconstituted by
incubation with cyclin B–Cdc2, but treatment with
cyclin B–Cdc2 did not result in the same reduction in
mobility of MP75 and Sox3 as was observed following incu-
bation in mitotic extract. The mobility of two proteins,
MP105 and MP70, was not altered at all by incubation with
Table 2
Characterization of the mitotic phosphoproteins.
Identical GenBank References References 
amino acids/ MAP accession Substrate (possible (mitotic phos-
Possible Amino-acid total sequenced Cdc2 kinase number of Cdc2 G2/M phorylation
Clone Homolog* function identity (%) amino acids† sites‡ sites‡ of MP in vitro§ function) in vivo)
MP130 C-INCENP Mitotic spindle 47% 416/876 3 3 U95094 ++ [34]
MP75 H-E-MAP-115 Microtubule stability 41% 65/158 1 2 U95101 + [33] [33]
MP110 H-Cdc5 G2 transcription 86% 141/164 5 2 U95093 ++ [35]
Oct91 X-Oct91 Transcription 88% 77/81 1 0 U04869 ++ [40] [40]
MP30 H-NC-2a Transcription 80% 96/119 0 1 U95096 ++
MP70 M-BRG-1 Transcription 83% 239/288 1 1 U95107, U95108 – [43] [43]
Vent2 X-Vent2 Hox gene 99% 335/337 1 0 X98849 ++
Xbr1b X-Xbr1b Hox gene 100% 165/165 1 0 U43938 ++
MP48 X-Xbr1b Hox gene 83% 44/53 1 0 U95099 ++
Sox3 X-Sox3 Hox gene 100% 31/31 0 2 Y07542 +
HoxD1 X-HoxD1 Hox gene 84% 21/24 1 2 L25857 ++
MP20 H-Ribosome Translation 78% 25/32 1 0 U95095 ND [27]
L18A
EF1g X-EF1g Translation 94% 16/17 1 0 S69726 ND [28]
MP25 H-Bat, RNA helicase 82% 37/45 1 0 U95105, U95106 ND [46]
Dm-WM6 77% 35/45
MP105 H-GPI anch- Unknown 71% 83/117 0 0 U95092 –
ored protein
MP90 Ce ORF Unknown 34% 208/598 1 1 U95102 +
T04C10.2,
Sc ORF 29% 126/435
Z67750
MP44 Ce ORF Unknown 20% 75/351 0 3 U95098 ++
R06F6.5,
Sc ORF 23% 80/351
YM8520.02
MP43 None Unknown 1 2 U95097 ++
MP68 None Unknown U95100 ++
MP42 None Unknown U95103, U95104 ++
*The names of homology clones are prefixed by letters indicating the
species: chicken (C), human (H), Xenopus (X), mouse (M), Drosophila
(Dm), C. elegans (Ce), and S. cerevisiae (Sc). ORF denotes an open
reading frame. †Except for MP130, MP90, MP44 and MP43, the clones
were only partially sequenced on one strand. Therefore, the degree of
homology is presented as the number of identical amino acids relative
to the number of amino acids coded within the sequenced region.
‡Consensus phosphorylation sites for Cdc2 and mitogen-activated
protein (MAP) kinase were taken as Ser/Thr–Pro–X–Arg/Lys and
Pro–X–Ser/Thr–Pro, respectively. Unless the identified clone was fully
sequenced, the kinase consensus site information was generated from
the homologous clone. §The ability of purified cyclin B1–Cdc2 to alter
the gel mobility of the MPs in vitro was compared to the mobility shifts
produced in a mitotic extract in an experiment similar to that shown in
Figure 2a, and scored as either no shift by Cdc2 (–), partial shift when
compared to mitotic extract (+), or the same shift as the mitotic extract
(++); some proteins were not scored (ND) because phosphorylation of
the clone did not cause a significant gel-mobility change.
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purified cyclin B–Cdc2. The results of similar assays per-
formed with the MPs that were identified by MPM-2
recognition and that change mobility in extracts are summa-
rized in Table 2. 
Discussion
In a nonsaturated, systematic screen for gene products that
are phosphorylated by cell-cycle-regulated protein kinases,
we have identified 20 different proteins that are phospho-
rylated in a mitosis-specific manner. At least 6 of these MPs
are MPM-2 antigens; 15 share sequence similarity with pre-
viously characterized proteins, and the other 5 appear not to
have been identified previously. Of the 16 proteins tested,
14 were substrates of cyclin B–Cdc2 in vitro. 
Possible roles of mitotic phosphoproteins in mitosis
Microtubules are reorganized during mitosis to generate a
spindle. E-MAP-115, a homolog of MP75, appears to sta-
bilize microtubules in interphase [32]. E-MAP-115 is
bound to microtubules during interphase, dissociates from
microtubules during early prophase, and slowly reassoci-
ates with the spindle after late prophase [33]. Moreover,
E-MAP-115 is hyperphosphorylated in mitosis in vivo, and
hyperphosphorylated E-MAP-115 does not bind micro-
tubules in vitro [33]. Therefore, the screening method has
identified a protein that appears to be regulated by
mitosis-specific phosphorylation.
INCENP (MP130) also appears to have a mitotic role. In
somatic cells, INCENP is bound to chromosomes in
prophase, moves to the centromeres at metaphase,
migrates to the polar microtubules in anaphase, and finally
resides in the midbody [34]. The multiple mitotic phos-
phoforms of INCENP in vivo provide a potential mecha-
nism for regulating INCENP localization; we are currently
determining whether nonphosphorylatable mutants of the
INCENP protein still exhibit dynamic localization pat-
terns during the cell cycle. 
MP110 is similar to Cdc5 of S. pombe and to a presump-
tive human homolog [35,36]. In S. pombe, the cdc5+ gene is
essential; cdc5– cells replicate their DNA but are unable to
undergo mitosis [35]. Cdc5 is related to the Myb trans-
criptional activator, binds DNA cellulose, and may be a
transcription factor active only during the G2 phase of the
cell cycle [35]. 
In fact, mitotic phosphorylation may be a general mecha-
nism to remove regulatory proteins from chromatin. There
is a decrease in transcription during mitosis [37,38], and a
number of transcription factors are phosphorylated during
mitosis, including the homeobox gene GHF-1, Myc, Myb,
BRG1, Oct1, Swi5 and TFIID [39–43]. We have added
eight new members to this list, suggesting that transcrip-
tion factors may be generally phosphorylated in mitosis.
Moreover, mitotic phosphorylation dissociates a number
of transcription factors from chromatin, including Myb,
BRG1 and GHF-1 which are homologous to MP110,
MP70 and the Hox genes, respectively [39,41–43]. Tran-
scription factors may need to be removed from DNA
during mitosis either to allow proper chromosome conden-
sation [44] or to allow the rearrangements of promoter
structures that are important for subsequent changes in
gene expression [42]. 
Protein synthesis is inhibited as Xenopus embryos enter
mitosis, although the mechanism by which this is accom-
plished is unclear [45]. We have identified two mitotic
phosphoproteins that are potentially involved in transla-
tional regulation, and therefore may be important cell-
cycle regulators of protein synthesis. EF1g, which is
associated with the GTPase complex that regulates transla-
tional elongation, has previously been shown to be a sub-
strate of Cdc2 [28]. Protein L18A (MP20) is a subunit of
the 60S ribosomal complex whose role in translation is as
yet unknown [27]. The WM6 protein (MP25) is presumed
to be an RNA helicase and is highly related to translational
elongation factor 4A, but a role in translation has not been
established. Overproduction of the Drosophila WM6
Figure 3
MP130 (X-INCENP) is phosphorylated more during mitosis than during
interphase in vivo. (a) The relative mobility of X-INCENP during
interphase (I, 40 min) or mitosis (M, 80 min) is compared between the
endogenous X-INCENP in embryos traversing the early embryonic cell
cycles (in vivo) and MP130 translated and incubated in cell-cycle
extracts (in vitro). The reduced gel mobility of X-INCENP is caused by
phosphorylation, as incubation of the mitotic form of X-INCENP with
calf intestinal phosphatase (M + CIP) produces a single band of faster
migration. (b) Xenopus eggs were fertilized and, at the indicated times,
five egg samples were analyzed both to determine the gel mobility of
endogenous X-INCENP by immunoblot analysis and for kinase activity
against histone H1 to determine the cell-cycle state. The relative
amount of H1 kinase activity and the relative percentage of the most
slowly migrating form of X-INCENP were quantitated.
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protein in S. pombe suppresses the mitotic catastrophe
induced by mutation of wee1 and overproduction of Cdc25
[46]. This phenotype is difficult to explain but could indi-
cate that WM6 has a role in mitotic regulation.
One reason that we set out to identify mitotic phospho-
proteins was to discover new regulators of mitosis. We
have identified five proteins that do not share sequence
similarity to previously characterized proteins. As many of
the proteins that we have identified do have roles in
mitosis, it seems reasonable to further characterize the
newly identified proteins. 
The complexity of mitotic phosphorylation
Mitosis brings many changes in cell structure. In higher
eukaryotes, the nuclear envelope dissolves, the Golgi appa-
ratus and endoplasmic recticulum fragment, actin cables
and interphase microtubules disappear, chromosomes con-
dense, and the mitotic spindle forms. Our screen has not
revealed proteins that, between them, localize to all of
these structures, nor identified all of the known mitotic
phosphoproteins — but we do not believe that the library
has been screened to saturation. Most clones were identi-
fied only once, and over 75 library pools containing mitoti-
cally phosphorylated proteins remain to be subdivided. We
estimate that at least 100 additional mitotic phosphopro-
teins could be identified using this method: in this initial
sample, approximately 1 of every 500 genes screened
(0.2% of the clones) was found to encode a mitotic phos-
phoprotein — extrapolation to the approximately 100 000
genes in the Xenopus genome indicates that 200 genes
encode mitotic phosphoproteins that could potentially be
detected by our methods. It is possible that a saturating
screen could identify a large percentage of the mitotic
phosphoproteins, providing a global view of mitotic phos-
phorylation in a manner similar to the recent quantification
of all RNA transcription from budding yeast [47]. Even
though our screen has to date identified less than 10
percent of the predicted number of targets, the limited
analysis presented in this paper suggests that a large per-
centage of the proteins phosphorylated during mitosis may
be transcriptional and translational regulators. 
The panel of MPs isolated in our screen has enabled us to
begin to address general questions concerning the com-
plexity of mitotic phosphorylation and the role of
cyclin B–Cdc2 in establishing the mitotic state. Most of the
clones tested (14/16) appear to be substrates of
cyclin B–Cdc2 in vitro. If we assume that the panel of sub-
strates identified is a random assortment of mitotic phos-
phoproteins, then this result suggests that a majority of
mitotic phosphorylation reactions may be carried out by
Cdc2 itself. Although phosphorylation of a substrate in vitro
does not of itself reflect substrate specificity in vivo, most of
the MPs contain Cdc2 consensus phosphorylation sites,
and the phosphorylation in Xenopus egg extracts of all of the
MPs coincides temporally with Cdc2 activation (data not
shown). Although it is formally possible that the
cyclin B–Cdc2 that we add to the in vitro translated sub-
strates is activating kinases in the reticulocyte lysate, this
seems unlikely considering the differentiated state of retic-
ulocytes and the five-fold dilution of the lysate in the assay.
The possibility that additional mitotic kinases play signifi-
cant roles in mitosis is suggested by the finding that puri-
fied cyclin B–Cdc2 did not phosphorylate two MPs at all
(MP70 and MP105) and did not reconstitute the full
mobility shifts of three others (Sox3, MP75 and MP90). At
least six non-CDK kinases become activated in mitosis, as
shown by chromatographically fractionating interphase
and mitotic extracts, depleting CDKs from each fraction,
and then assaying the fractions for the ability to phos-
phorylate MPs (P.T.S. and M.W.K., unpublished observa-
tions). MP phosphorylation is a simple and specific assay
that should facilitate the biochemical purification and
characterization of these kinase activities. Thus, our data
support a model of mitotic control in which both Cdc2 and
additional protein kinases become activated during
mitosis to execute mitotic phosphorylation.
Screening by enzymatic activity
We have described a systematic screening technique in
which proteins encoded in a cDNA library are individually
tested for a chosen activity. One strength of this approach
is that it can be combined with the use of Xenopus egg
extracts, which can reconstitute in vitro most of the key
regulatory and structural events of the cell cycle that occur
in vivo. This property is important for the study of equilib-
rium activities such as phosphorylation. 
A method for identifying mitotic phosphoproteins was
described by Westendorf, Rao and Gerace [48]. They incu-
bated filters derived from lambda gt11 libraries with
mitotic extracts from HeLa cells, and then probed the
filters with the MPM-2 antibody [27,48]. Using this
method, they identified 10 mitotic phosphoproteins after
screening over 800 000 bacterially expressed clones [27,48].
The Xenopus homolog, MP20, of one of them was also iso-
lated by the method described here. The small-pool screen
that we carried out had a much higher rate of detection of
MPM-2-reactive proteins (about 1 in every 500 clones
tested). There are three primary differences between the
two screening techniques that may explain this difference
in detection frequency. First, proteins translated in vitro
contain post-translational modifications, and may be more
properly folded than bacterially overproduced proteins on
nitrocellulose filters. Second, the phosphorylation reactions
in our screen were performed in solution, rather than on
filters. Third, because the Xenopus cell extracts are very
concentrated (40–50 mg ml–1), they may be a richer source
of mitotic protein kinases than the HeLa cell extracts used
by Westendorf et al. [48]. These differences presumably
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increase the efficiency with which library proteins are rec-
ognized by mitotic kinases and by the MPM-2 antibody.
Moreover, it is clear that a large percentage of mitotic phos-
phoproteins are not recognized by MPM-2, and therefore
the detection of mitotic phosphoproteins by gel-mobility
shift in addition to MPM-2 antibody reactivity allows a
wider range of substrates to be identified. 
There are three limitations of our screening technique;
first, it cannot detect kinase substrates that neither react
with anti-phosphoepitope antibodies nor show a signifi-
cant gel-mobility shift upon phosphorylation. Second,
proteins that would be inaccessible to cytoplasmic
mitotic kinases when localized normally may be aber-
rantly phosphorylated in the extracts; examples of such
proteins may be MP105, which is related to a GPI-
anchored protein, and MP42, which contains a potential
signal sequence. Third, in pools of approximately 100
clones, an average of 24 35S-labeled protein bands were
detected, suggesting that not all of the cDNAs were
being assayed. This problem, however, can be largely cir-
cumvented by using smaller pools of clones (approxi-
mately 36 clones per pool; see Materials and methods for
details). 
Other applications of the small-pool protein screen
The protein pool screening approach can be adapted to a
wide range of existing in vitro and in vivo assays. Using
small pools of library proteins, screens for substrates, inter-
actions, or activities can be carried out [49]. Screens like
the one we report here should be broadly applicable for
the identification of substrates of any purified or partially
purified enzymatic activity. Indeed, this approach has
already been adapted successfully for screening for pro-
teins that are specifically degraded during mitosis (T.J.M.
and M.W.K., unpublished observations) as well as for pro-
teins that are specifically degraded by ICE proteases (V.
Cryns and J. Yuan, and D. Xue and R. Horvitz, personal
communications). We have also modified this approach in
order to identify substrates of a single kinase,
cyclin E–Cdk2; this was accomplished by comparing the
gel mobility of labeled protein pools after incubation in
interphase extracts in either the presence or absence of
the specific kinase inhibitor p21 (P.T.S. and M.W.K.,
unpublished observations). 
Conclusions
In this study, we have described a systematic and broadly
applicable approach for identifying mitotic phospho-
proteins. Further characterization of the 20 kinase sub-
strates that we have thus far isolated should provide new
insights into their roles in both mitosis and the signal-trans-
duction cascades that orchestrate cell-cycle states. The
general approach we have developed is not limited to iden-
tifying kinase substrates, but can be used, at least in princi-
ple, to systematically identify substrates of enzymatic
activities that have previously proven intractable to genetic
or biochemical isolation. 
Materials and methods
Materials
All chemicals were supplied by Sigma unless stated otherwise. MPM-2
antibody ascites fluid was prepared as described previously [9].
INCENP antibodies were a generous gift from W. Earnshaw [34] and
Cdc2 antibodies have been described previously [50]. Immunoblots
were performed as described [51]. Fusion proteins consisting of glu-
tathione S-transferase fused to Xenopus cyclins (GST–cyclins) were
expressed in E. coli, purified by glutathione affinity chromatography as
described [13] and stored in XB (10 mM HEPES pH 7.7, 1 mM MgCl2,
0.1 mM CaCl2, 100 mM KCl, 50 mM sucrose, 1 mM DTT and
10 mg ml–1 leupeptin, pepstatin A and chymostatin) at –80°C until use.
Initial sequencing to identify clones was performed on one strand
according to the manufacturer’s directions (US Biochemical Corpora-
tion); complete sequencing of clones was performed on both strands in
polymerase chain reactions in the presence of 4 fluorescent dideoxy ter-
minators (Perkin Elmer), and analyzed on an Applied Biosystems 373A
DNA sequencer by the Harvard Medical School biopolymers facility.
Preparation of cDNA and protein pools, and progressive
subdivision of positive pools to single clones
Previously, we have used pools of library cDNA plasmids (containing
100 clones per pool) to construct RNA pools which were then trans-
lated and assayed in vivo, in Xenopus oocytes [20,21] or Xenopus
embryos [52]. In this study, we have used the same pools of cDNAs to
directly construct pools of proteins in vitro. Protein pools were pre-
pared using the TnT Coupled Reticulocyte Lysate System from
Promega, according to the manufacturer’s instructions, except that the
reaction volume was scaled down to 5 or 10 ml and we added
0.1–0.5 mg of pooled plasmid cDNA per reaction. Radioactively-
labeled protein pools were prepared by carrying out a 10 ml translation
reaction in the presence of 8 mCi [35S]methionine (1000 Ci mmol–1)
and omitting unlabeled methionine from the amino-acid mix. Protein
pools were stored on ice and used on the day of synthesis. Positive
pools were subdivided as described [49].
In pools of approximately 100 clones, an average of 24 35S-labeled
protein bands were detected. The low number of translation products
suggests that only one quarter of the cDNAs within the library were
being tested. We tested smaller pools of cDNAs to determine if we
could detect a greater percentage of the clones. When tested individu-
ally, only 63% of the plasmids from the library could give a translatable
product, which only partially explains the low number of proteins trans-
lated in pools of 100 clones (P.T.S. and M.W.K., unpublished observa-
tions). When smaller pools of 32 and 24 clones/pool were transcribed
and translated they produced an average of 22 and 18 bands (P.T.S.
and M.W.K., unpublished observations). As 63% of clones in this library
can give a protein product, then these smaller pools should yield an
average of 20 and 18 bands, respectively; therefore, most of the cDNAs
were giving recognizable product when smaller pools were used. 
Preparation of interphase and mitotic Xenopus extracts 
Interphase extracts (IE) were prepared from unfertilized eggs obtained
from Xenopus as described previously [23], with the following
modifications. De-jellied meiotically arrested eggs in 1× MMR (5 mM
HEPES pH 7.4, 100 mM NaCl, 2 mM KCl, 2 mM CaCl2, 1 mM MgCl2)
were activated by the addition of 2 mg ml–1 A23187, a calcium
ionophore, kept at 18°C and then crushed 50 min later. Just before
freezing in liquid N2, 100 mg ml–1 cycloheximide and 10% glycerol
were added; extracts were stored at –80°C until used. Cycloheximide-
presoaked IE were prepared as above except that the eggs were
soaked for 15 min in 100 mg ml–1 cycloheximide (which was contained
in all subsequent buffers) before ionophore activation and that the
extracts were prepared approximately 20 min after activation. Mitotic
extracts were prepared by driving IE into mitosis by the addition of
66 nM nondegradable GST–cyclin B for 30 min at room temperature
(IE + cyclin B). 
Identification of MPs by retarded gel mobility 
A 1.5 ml aliquot from a [35S]methionine-labeled protein pool was added
to 4.5 ml IE or IE + cyclin B. The reactions were incubated at room tem-
perature for 60 min and then terminated by adding 22.5ml of 2× sample
buffer (7.5% glycerol, 240 mM Tris, 37.5 mM DTT, 0.75% SDS and
0.075% Bromophenol Blue). Labeled proteins were resolved by
SDS–PAGE and visualized by autoradiography. Positive proteins had a
retarded mobility after incubation in IE + cyclin B when compared with IE.
MPM-2 immunoprecipitation of in vitro translated proteins 
[35S]methionine-labeled protein pools (4 ml) were mixed with 4 ml of
either IE or IE + cyclin B containing 0.5 mM okadaic acid (CalBiochem),
and the reaction mixture was then incubated at room temperature for
30 min. MPM-2 beads (15 ml; prepared as in [53]) were washed 2
times with 500 ml EB (80 mM b-glycerolphosphate, 20 mM EGTA,
10 mM MgCl2) containing 5 mM NaF, and an additional 10 ml EB con-
taining 5 mM NaF was added to the beads. Extracts (3 ml) and labeled
pooled protein mixture were added to the MPM-2 bead slurry and sub-
sequently rotated for 1 h at 4°C. The beads were washed 3 times in
500 ml of MPM-2 wash buffer (EB containing 5 mM NaF, 500 mM
NaCl, 1.0% NP40), then 20 ml of 2× sample buffer was added and the
samples were boiled for 5 min. Translation mixture (1 ml) from each
pool was directly diluted into sample buffer and loaded onto 5–15%
SDS–polyacrylamide gradient gels adjacent to the proteins immuno-
precipitated from IE and IE + cyclin B extracts [54].
In the MPM-2 immunoprecipitation primary screen, the phosphatase
inhibitor okadaic acid, which stabilizes the mitotic state, was added to the
mitotic extracts to increase the sensitivity of the assay. Okadaic acid
increased the percentage of the clone MP90 precipitated by MPM-2
over 5-fold, but for most of the positive clones had little or no effect on
the amount of protein precipitated by MPM-2 (data not shown). Two
clones (Vox1 and BRG1) exhibited a phosphatase-sensitive reduction in
SDS–PAGE mobility after incubation in mitotic extracts but were only
immunoprecipitated by MPM-2 in the presence of okadaic acid (data not
shown). Okadaic acid was not added when single proteins were assayed 
Fertilization of Xenopus eggs, and early embryonic time
course
Xenopus eggs were obtained as described [23] by gentle squeezing
into 1× MMR. The eggs were fertilized with fresh sperm, activated by
the addition of nine volumes of water, and de-jellied about 10 min later
with 2% cysteine in 1× XB salts (1 mM CaCl2, 1 mM MgCl2, 100 mM
KCl). At each indicated time point, five eggs were added to 100 ml sta-
bilization buffer (40 mM b-glycerophosphate, 20 mM NaF, 10 mM
EDTA, stored at 0°C), homogenized by pipetting up and down, and
then spun for 15 sec at 14 000 r.p.m. in a Sorval MC15 microfuge to
remove lipid and yolk platelets. Immediately after centrifugation, 10 ml
of the supernatant was frozen in liquid N2 for histone H1 kinase assays.
These were carried out as described [23], except that the final MgCl2
concentration was 11 mM. The rest of the sample was diluted into
sample buffer and stored at –20°C until the samples were loaded onto
a 7% gel for immunoblot analysis. For graphic analysis, the results of
the immunoblot and histone H1 kinase assays were digitized, and the
amount of phosphorylated INCENP and histone H1 kinase activities
were quantitated using the IP lab gel version 1.5 (Signal Analycs).
Because there was some variability in the amount of total INCENP
signal on the blot, the amount of phosphorylated INCENP was divided
by the total INCENP signal, and this ratio was plotted as a percentage
of maximal ratio differences. Histone H1 kinase activity was plotted as
the percentage of maximal total activity in the sample.
Kinase assays with purified cyclin B1–Cdc2 complexes
GST–cyclin B1–Cdc2 was purified by rocking 100 ml IE + cyclin B
extract, diluted into 300 ml IP buffer (100 mM NaCl, 50 mM b-glyc-
erophosphate pH 7.2, 5 mM EDTA, 0.1% Triton X-100, 1 mM DTT,
and 10 mg ml–1 leupeptin, pepstatin A and chymostatin), with 100 ml
glutathione-agarose beads for 1 h at 4°C. The beads were washed
four times with IP buffer, two times in kinase buffer (50 mM NaCl,
20 mM HEPES pH 7.2, 10 mM MgCl2, 2 mM EDTA, 0.02% Triton X-
100), and then eluted with 100 ml of XB containing 5 mM reduced
glutathione. Control solutions were similarly prepared except that
agarose beads without the affinity ligand were used (Biorad Affigel
102). For in vitro kinase assays 5 ml of either IE, IE + cyclin B, puri-
fied GST–cyclin B1–Cdc2, or Cdc2 control solution was incubated
with 1 ml of the indicated protein for 10 min at room temperature, and
the reaction was quenched with sample buffer. Half of the
IE + cyclin B reaction (which was scaled up 2-fold) was removed
before addition of sample buffer, and incubated with 5 mg calf intesti-
nal phosphatase (Boehringher Mannheim) for 30 min at 37°C.
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